---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-018072"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2024-05-23T23:59:59+00:00"
generated_at: "2026-06-01T09:13:06.281956+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics regains Nasdaq compliance on equity rule; remains under Panel Monitor until May 2025

## Summary
- Notified by Nasdaq on May 21, 2024, that it meets minimum stockholders' equity requirement for continued listing.
- Previously disclosed listing matter is now closed.
- Subject to a Panel Monitor for one year (through May 21, 2025).
- If equity rule is not satisfied during monitoring, loses compliance plan option and must request a hearing.
- Company trades as ATXI on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001437749-24-018072
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2024-05-23T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000143774924018072/0001437749-24-018072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000143774924018072/atxi20240522_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-018072
- JSON: https://secwatch.observer/filing/0001437749-24-018072.json
- Plain text: https://secwatch.observer/filing/0001437749-24-018072.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.